Background: Nickel allergy and dermatitis have been associated with filaggrin gene mutations in epidemiological studies, but the mechanisms mediating these associations are unknown.
1
Filaggrin, which is a quantitatively and qualitatively important protein of the stratum corneum (SC), aggregates keratin filaments during the terminal differentiation of keratinocytes, leading to compaction of the cells. 2 Common loss-of-function mutations in the filaggrin gene (FLG) cause ichthyosis vulgaris, and dramatically increase the risk of atopic dermatitis (AD). [2] [3] [4] Studies have also shown that FLG mutations might be associated with nickel allergy and ACD, as well as stronger nickel patch test reactions. [5] [6] [7] Although the mechanisms mediating the association between nickel allergy and FLG mutations are unknown, increased epidermal penetration of nickel because of a reduction in chelating histidine is a possibility. 8, 9 Epidermal deficiency of filaggrin is also associated with steadystate skin inflammation. [10] [11] [12] [13] [14] For example, increased levels of interleukin (IL)-1β are found in the SC of uninvolved skin and in blister fluid of acute lesional skin of AD patients with mutations in FLG as compared with AD patients without mutations, 11, 15 as well as in skin from flaky tail (ft/ft) mice with a loss-of-function mutation in FLG. 16 Moreover, the ft/ft mice already have IL-17A-dominated skin inflammation at the age of 8 weeks. 12, 13 Interestingly, both IL-1β and IL-17A are important cytokines during the inflammatory response to contact allergens, indicating that epidermal filaggrin deficiency could indeed increase an ACD response on the basis of steady-state inflammation. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] In this study, we found that ft/ft mice showed increased immune reactivity to nickel as compared with wild-type (WT) mice. Accordingly, we found increased ear thickness upon challenge with 2,4-dinitrofluorobenzene (DNFB) and cinnamal in ft/ft mice as compared with WT mice. Interestingly, no difference in the response was found upon challenge with p-phenylenediamine (PPD). Furthermore, a reduced amount of nickel was found in the skin of ft/ft mice as compared with that of WT mice 20 hours after nickel exposure, indicating increased nickel penetration into ft/ft skin. In accordance with previous studies, ft/ft mice showed increased steady-state epidermal expression of both IL1β and IL17A, and blocking either the IL-17A
pathway or the IL-1 pathway decreased the nickel response in ft/ft mice. Collectively, the results of our study suggest that the association between nickel allergy and epidermal filaggrin deficiency is probably mediated by a combination of increased nickel penetration and steady-state skin inflammation.
| MATERIALS AND METHODS

| Mice
Flaky tail mice (STOCK a/a Tmem79 ma Flg f /J) were purchased as cryopreserved embryos from Jackson Laboratory (Bar Harbor, Maine) and bred in our animal facility. Age-matched and sex-matched C57BL/6 mice and BALB/c (WT) mice were purchased from Taconic (Ry, Denmark) and Janvier (Le Genest-Saint-Isle, France). All mice were housed in specific pathogen-free facilities at the Department of Experimental Medicine, Panum Institute, The University of Copenhagen, in accordance with national animal protection guidelines (licence number:
2012-15-2934-00663). The mice were between 7 and 12 weeks of age at the onset of the experiments.
| Contact hypersensitivity
Mice were sensitized and challenged with 10% (wt/wt) nickel(II) chloride (NiCl 2 ) (Sigma-Aldrich, Brøndby, Denmark) (~0.69 mol/L) in white petrolatum or vehicle (pure pet.), as previously described. 26 In addition, groups of mice were sensitized and challenged with either 0.15% DNFB, 6.0% cinnamaldehyde (cinnamal) or 1% PPD as previously described. 
| IL-1β measurements in ears
Ears of euthanized mice were excised and snap-frozen in liquid nitrogen. The frozen mouse ears were homogenized in lysis buffer (50 mM Tris base, 250 mM NaCl, 5 mM EDTA, 1% Triton X-100, pH 7.4) supplemented with protease complete inhibitor cocktail (Roche, Hvi- 
| Flow cytometry
Single-cell suspensions from draining lymph nodes were stimulated at 1 × 10 7 cells/mL with 50 ng/mL phorbol 12-myristate 13-acetate, 
| Statistical analysis
Statistically significant differences between groups were evaluated with Student's unpaired, two-tailed t test. In experiments with multiple mouse strains and experimental conditions, respectively, differences were statistically evaluated by two-way ANOVA followed by
Bonferroni's multiple comparisons test. GRAPHPAD PRISM 6.0 software was used for the analysis. P-values of <0.05 were considered to be statistically significant.
3 | RESULTS
| Flaky tail mice show an increased response to nickel
First, we investigated whether the response of ft/ft mice to nickel was different from that of WT mice. As the ft/ft mice are of a mixed background, both C57BL/6 and BALB/c mice were used as WT controls. To investigate the response to nickel, mice were sensitized and challenged with 10% NiCl 2 (~0.69 mol/L) as shown in Figure 1A , with a model that we have previously developed. 26 Nickel allergy was induced in both ft/ft and WT mice, measured as increases in ear thickness and IL-1β levels in the ears upon nickel challenge ( Figure 1B,F) .
Interestingly, the challenge response to nickel was significantly stronger in ft/ft mice than in WT mice ( Figure 1B,F) . Additionally, we found 
| Allergen-dependent effect of lack of filaggrin
Next, we investigated whether the increased nickel response was attributable to a generally increased response to contact allergens in ft/ft mice. We selected three different contact allergens: the experi- 
| Reduced amounts of nickel in the skin of ft/ft mice
The increased response to nickel found in ft/ft mice might be mediated by increased nickel penetration. To investigate this, mice were exposed to 10% NiCl 2 . After 20 hours, we determined the amount of nickel in the skin by using ICPMS. A 20%-30% reduced amount of nickel was found in ft/ft mice as compared with WT mice (Figure 3 ), indicating increased absorption of nickel by the skin of ft/ft mice.
| IL-17A-driven increased response to nickel in ft/ft mice
In addition to increased nickel penetration, the steady-state skin inflammation found in ft/ft mice probably plays a role in mediating the increased nickel response. In agreement with previous studies, we found higher expression of both IL1β and IL17A in the epidermis of vehicle-treated ft/ft mice than in that of WT mice ( Figure 4B ,C).
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IL17A expression was more than 100-fold higher in the epidermis of ft/ft mice than in that of WT mice. Interestingly, whereas 2 days of nickel exposure enhanced IL1β expression in the epidermis in both ft/ft and WT mice, nickel exposure had only a minor effect on IL17A after sensitization and challenge with vehicle or nickel. Data are mean AE standard error of the mean of two to six independent experiments with four or five mice per group. *P < 0.05, **P <0 .01, ***P < 0.001, ****P < 0.0001 response to nickel, ft/ft mice were treated with anti-IL-17A 1 day before and during 2 days of exposure to nickel ( Figure 4I ). Anti-IL-17A treatment resulted in a reduction in ear swelling and a 40% reduction in epidermal IL1β expression induced by nickel exposure as compared with mice treated with isotype control (Figure 4J,K) . Taken together, these observations suggest that IL-17A plays a role in driving the increased primary response to nickel found in ft/ft mice.
| Blocking the IL-17A pathway during sensitization reduced the challenge response to nickel
Next, we examined the effect of anti-IL-17A treatment during sensitization on the challenge response to nickel ( Figure 5A ). Inhibition of IL-17A during sensitization was found to lower the challenge response to nickel as measured by a reduction in ear swelling ( Figure 5B ). To further investigate the effect of inhibiting IL-17A, ft/ft mice were treated orally with a RORγt inhibitor (GSK805) before, during and after nickel sensitization ( Figure 5C ). Interestingly, treatment with GSK805 lowered the nickel-induced ear swelling to almost the same extent as treatment with anti-IL-17A antibody ( Figure 5D ).
| Reduced response to nickel following treatment with anakinra
As we have previously shown that the response to nickel in mice requires the IL-1 pathway, 26 we investigated the effect of treating ft/ft mice with the IL-1 receptor antagonist anakinra. To this end, ft/ft . Data are mean AE standard error of the mean of two independent experiments with four or five mice per group. P <0 .05, **P < 0.01, ***P < 0.001, ****P < 0.0001. ft/ft, flaky tail 
| DISCUSSION
This study has shown that filaggrin-deficient ft/ft mice have an increased skin response to nickel as compared with WT mice, most likely facilitated by a combination of increased nickel penetration and increased steady-state skin inflammation found in these mice.
Increased penetration of fluorescein isothiocyanate and calcium green upon epicutaneous exposure has been observed in ft/ft mice as compared with C57BL/6 mice. 12, 14 Furthermore, epicutaneous exposure to either ovalbumin or Dermatophagoides pteronyssinus induced stronger immune responses in ft/ft mice than in WT controls. 12, 13 These observations suggest that epicutaneous exposure to any contact allergen in filaggrin-deficient skin would result in a stronger ACD response than in normal skin. However, whereas we observed a strongly increased response to nickel in ft/ft mice as compared with WT mice, application of DNFB resulted in a more moderately increased response, and cinnamal application resulted in only a slightly increased response, in ft/ft mice as compared with WT mice. Finally, PPD application resulted in similar responses in ft/ft and WT mice.
As filaggrin is very histidine-rich, and nickel binds to histidine, it is likely that most nickel is bound to filaggrin in the SC of normal skin, whereas nickel rapidly penetrates into the viable layers of the epidermis in filaggrin-deficient skin. 8 Similarly, it has been shown for trivalent chromium that filaggrin degradation products can chelate chromium and prevent its penetration beyond the SC. 30 In line with that observation, we found a reduced amount of nickel in the skin of ft/ft mice as compared with WT mice 20 hours after nickel exposure, indicating increased penetration of nickel into the skin of ft/ft mice. However, to adequately study possible differences in nickel penetration, various nickel doses need to be applied to the skin, with measurements being performed at different time intervals. The moderately increased response to DNFB and cinnamal in ft/ft mice is probably mediated by steady-state skin inflammation, as both allergens are likely to penetrate skin with and without filaggrin proteins and degradation products. Co-exposure to mixtures of allergens and irritants increases the immune response, so, similarly, we suspect that the existing inflammation in ft/ft skin could reduce the inflammatory threshold for DNFB and cinnamal, and thereby explain the moderately enhanced responses to these allergens.
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Whereas we observed a weak response to cinnamal in WT mice, cinnamal completely failed to induce a response in C57BL/6 mice in a study by El Ali et al, 34 a discrepancy that probably resulted from the use of different models for contact hypersensitivity. Interestingly, mice deficient in the transcription factor nuclear-related factor 2 (Nrf2) did respond to cinnamal, and showed enhanced responses to the potent allergen dinitrochlorobenzene (DNCB). 34 Nrf2 is normally activated in innate immune cells to prevent excess accumulation of reactive oxygen species and electrophilic stress, for instance upon exposure to contact allergens. 34 Hence, these data further underline that a heightened proinflammatory state can indeed lower the activation threshold for both weak and strong contact allergens. challenge. Data are mean AE SEM of two independent experiments with three or four mice per group. *P < 0.05, **P < 0.01, ****P < 0.0001. ip, intraperitoneal; PBS, phosphate-buffered saline
In contrast to our findings, Moniaga et al found a more prominent change in ear thickness in ft/ft mice as compared with C57BL/6 mice after challenge with DNFB. 12 The difference in our results is possibly attributable to differences in experimental setups and DNFB concentrations. Furthermore, the steady-state inflammation could differ, as this is suggested to be driven by the microbiota present in the animal facilities. 35 In a study by Scharschmidt et al, no difference in the response was seen when ft/ft mice and C57BL/6 mice were exposed to high doses of the experimental allergen oxazolone, whereas exposure to low doses only induced responses in ft/ft mice. 14 It is therefore possible that we would have detected a difference in the response to PPD between ft/ft and WT mice if lower doses of PPD had been used.
Notably, allergic reactions to PPD are poorly understood, as several oxidation products of PPD can be formed, with various allergenic potentials involving various metabolic processes in the skin, which are likely to be different in ft/ft mice and WT mice. 36 However, this needs further investigation.
In accordance with previous studies, we found increased levels of IL-1β and IL-17A at steady state in the epidermis of ft/ft mice as compared with that of WT mice. [11] [12] [13] Exposure to nickel further increased the expression level of IL1β, but not that of IL17A. We have recently
shown that addition of IL-17A increases allergen-induced IL-1β production from keratinocytes. 21 Accordingly, we found that treatment with anti-IL-17A during the primary exposure to nickel resulted in a 40% reduction in epidermal IL1β expression as compared with isotype-treated ft/ft mice. These data indicate that the increased IL-17A level at steady state in ft/ft mice worked in synergy with nickel to enhance IL-1β production. However, given the reduction in IL-1β seen with anti-IL-17A treatment during the primary response to nickel, we had expected a more pronounced effect on the challenge response after anti-IL-17A treatment during sensitization. One explanation could be that intraperitoneal treatment with anti-IL-17A only induced partial inhibition of the IL-17A pathway in the skin. However, as we found nearly the same effect on the response following oral treatment with GSK805, this suggests that inhibition of IL-17A during nickel sensitization has only a minor impact on the nickel challenge response seen in ft/ft mice. Therefore, we find it likely that, whereas IL-17A plays a central role in the primary response to nickel, other cytokines, probably IFN-γ, are more important in the challenge response to nickel. 21 As RORγt also regulates the transcription of IL-17F and IL-22, 37 we cannot exclude the possibility that the reduced response seen in mice treated with GSK805 might be mediated by reductions in IL-17F and/or IL-22. Inhibition of the IL-1 pathway, either during sensitization or during challenge, reduced the response seen upon nickel challenge, indicating that this pathway plays an important role in the nickel response in ft/ft mice.
There are limitations to the interpretation of our results. Besides the mutation in Flg, ft/ft mice are also homozygous carriers of a mutation in Tmem79. We cannot rule out the possibility that the Tmem79 mutation plays a role in the increased nickel responsiveness. Moreover, ft/ft mice are on a mixed background, and the major histocompatibility complex (MHC) haplotype probably plays a role in the responsiveness to nickel. However, as an association between nickel allergy and mutations in FLG has been found in humans, [5] [6] [7] we think it unlikely that differences in MHC haplotype between ft/ft mice and WT mice can explain the increased nickel responsiveness found in ft/ft mice. As nickel allergy is the most frequent form of contact allergy, several attempts have been made to establish a mouse model for nickel allergy, with varied levels of success. [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] In 2010, Schmidt et al showed that nickel binds directly to human toll-like receptor 4 (TLR4), but not to mouse TLR4, which resulted in a general dogma that nickel allergy cannot be induced in mice without the addition of an adjuvant. 48 However, we have succeeded in establishing a mouse model for nickel allergy caused by epicutaneous nickel exposure that works independently of TLR4, and this model has been used in the current study. 26 In summary, we have shown that filaggrin-deficient mice have increased immune reactivity to nickel, supporting epidemiological studies that suggest an association between nickel allergy and FLG mutations. Our results further indicate that the IL-1 pathway is a potential target for treatment of nickel allergy in filaggrin-deficient eczema patients, although a defective barrier leading to enhanced nickel penetration also seems to be important for the increased nickel responsiveness associated with filaggrin deficiency.
